A prospective real-world analysis of erenumab in refractory chronic migraine
Abstract Background Clinical trials have shown the safety and clinical superiority of erenumab compared to placebo in chronic migraine (CM). The aim of this analysis is to evaluate the effectiveness and tolerability of erenumab in a real-world setting in patients with refractory CM. Methods This is...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2020-06-01
|
| coleção: | The Journal of Headache and Pain |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s10194-020-01127-0 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|